Uptake of the recently introduced vaccines among children aged 12-23 months in Ethiopia: a multilevel analysis of the 2019 Ethiopia Mini Demographic and Health Survey

埃塞俄比亚12-23个月龄儿童近期疫苗接种情况:基于2019年埃塞俄比亚小型人口与健康调查的多层次分析

阅读:2

Abstract

OBJECTIVE: Though vaccination coverage in Ethiopia has shown steady progress over the years, there are districts with below targeted vaccination coverage. This study assessed the magnitude and determinants of recently introduced vaccines uptake among children aged 12-23 months in Ethiopia. DESIGN: National cross-sectional study. SETTING: Ethiopia. PARTICIPANTS: Mothers with children aged between 12 and 23 months. OUTCOME MEASURES: The outcome variable was the uptake of recently introduced vaccines (rotavirus vaccine (RV) and pneumococcal conjugate vaccine (PCV)) among children aged 12-23. RESULTS: Our analysis revealed that 45.7%, 53.4% and 43.5% of the children completed vaccination with PCV, RV and both PCV and RV, respectively. Being in the age group of 20-34 (adjusted OR (AOR)=2.03, 95% CI: 1.37 to 3.02) and 35-49 (AOR=2.44, 95% CI: 1.52 to 3.91), having at least four antenatal care contacts (AOR=2.73, 95% CI: 2.06 to 3.62), having postnatal care (AOR=1.84, 95% CI: 1.42 to 2.37), delivery in the health facility (AOR=1.45, 95% CI: 1.17 to 1.79) and having exposure to media (AOR=1.24, 95% CI: 1.09 to 1.56) and any of the wealth quintile categories higher than poorest category were positively associated with the uptake of newly introduced vaccines. Rural residency was found to be negatively associated with the uptake of newly introduced vaccines. CONCLUSION: The overall full uptakes of newly introduced vaccines among children aged 12-23 months were significantly lower. Hence, this study emphasises the need to strengthen maternal and child healthcare services, particularly to the younger age mother and those with lower socioeconomic status.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。